MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA

被引：0
|
作者：
Shahzad, Q. [1 ]
Zaheer, M. [1 ]
机构：
[1] ST Lukes Gen Hosp Kilkenny, Resp Med, Kilkenny, Ireland
来源：
CHEST | 2020年 / 157卷 / 06期
关键词：
Mepolizumab; Eosinophilic Asthma;
D O I：
10.1016/j.chest.2020.05.337
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：275A / 275A
页数：1
相关论文
共 50 条
  • [21] Phenotyping Mepolizumab EXacerbations in severe eosinophilic asthma (MEX)
    McDowell, Pamela Jane
    Diver, Sarah
    Yang, Jieqiong Freda
    Borg, Catherine
    Busby, John
    Brown, Vanessa
    Shrimanker, Rahul
    Cox, Ciara
    Brightling, Christopher
    Chaudhuri, Rekha
    Pavord, Ian
    Heaney, Liam
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [22] Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility
    Humbert, Marc
    Albers, Frank C.
    Bratton, Daniel J.
    Yancey, Steven W.
    Liu, Mark C.
    Hozawa, Soichiro
    Llanos, Jean-Pierre
    Kwon, Namhee
    RESPIRATORY MEDICINE, 2019, 154 : 69 - 75
  • [23] Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
    Shimoda, Terufumi
    Odajima, Hiroshi
    Okamasa, Arisa
    Kawase, Minako
    Komatsubara, Masaki
    Mayer, Bhabita
    Yancey, Steven
    Ortega, Hector
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (03) : 445 - 451
  • [24] Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
    Takanori Numata
    Katsutoshi Nakayama
    Hirofumi Utsumi
    Kenji Kobayashi
    Haruhiko Yanagisawa
    Mitsuo Hashimoto
    Shunsuke Minagawa
    Takeo Ishikawa
    Hiromichi Hara
    Jun Araya
    Kazuyoshi Kuwano
    BMC Pulmonary Medicine, 19
  • [25] Real-life treatment of severe eosinophilic asthma with mepolizumab
    Pelaia, Corrado
    Busceti, Maria Teresa
    Solinas, Sabina
    Terracciano, Rosa
    Pelaia, Girolamo
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [26] Mepolizumab in real-life treatment of severe eosinophilic asthma
    Volakova, Eva
    Zatloukal, Jaromir
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [27] SMALL AIRWAY FUNCTION IMPROVEMENT WITH MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Farah, C.
    Seccombe, L.
    Rogers, P.
    Reed, N.
    Badal, T.
    Thamrin, C.
    King, G.
    Peters, M.
    RESPIROLOGY, 2018, 23 : 213 - 213
  • [28] Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
    Shrimanker, Rahul
    Hargaden, B.
    Bradding, P.
    Wardlaw, A. J.
    Brightling, C. E.
    Green, R.
    Bafadhel, M.
    Heaney, L.
    Pavord, I.
    Haldar, P.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [29] Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
    Numata, Takanori
    Nakayama, Katsutoshi
    Utsumi, Hirofumi
    Kobayashi, Kenji
    Yanagisawa, Haruhiko
    Hashimoto, Mitsuo
    Minagawa, Shunsuke
    Ishikawa, Takeo
    Hara, Hiromichi
    Araya, Jun
    Kuwano, Kazuyoshi
    BMC PULMONARY MEDICINE, 2019, 19 (01)
  • [30] IMPACT OF WEIGHT ON THE EFFICACY OF MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Ortega, H.
    Albers, F.
    Llanos-Ackert, J.
    Bradford, E.
    Price, R.
    Pouliquen, I.
    Castro, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : E3 - E4
12345